CSOP Hang Seng Biotech ETF (03174.HK) Fell 1.62% to 13.990

Newtimespace News, as of 09:41 on May 15, CSOP Hang Seng Biotech ETF (03174.HK) was quoted at HKD 13.990, down 1.62%. The ETF opened at HKD 14.220, with a high of HKD 14.230 and a low of HKD 13.980. The latest Net Asset Value (NAV) per unit is HKD 14.283, with a premium rate of -0.44%. The asset size is approximately HKD 2.217 billion.

CSOP Hang Seng Biotech ETF (03174.HK) tracks the Hang Seng Biotech Index, which is compiled and published by Hang Seng Indexes Company Limited. The index aims to reflect the overall performance of the 30 largest biotech companies by market capitalization that are listed in Hong Kong and eligible for Southbound Stock Connect trading. Its constituent holdings cover four major business sub-categories: pharmaceuticals, biotechnology, pharmaceutical distribution, and medical equipment & supplies. It specifically focuses on core, high-growth biotech sectors such as innovative drugs, CXO (Contract Research Organization), and medical devices.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.